First Manhattan CO Amarin Corp Plcuk Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	BUY	$5.03 - $8.8 $10,060 - $17,600	2,000 New	2,000 $12,000
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $4.17 Million - $7.21 Million	-873,300 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$4.0 - $21.53 $3.49 Million - $18.8 Million	873,300 New	873,300 $3.49 Million
Q4 2018 Jan 30, 2019	SELL	$12.41 - $22.98 $7,446 - $13,788	-600 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$2.45 - $16.27 $1,470 - $9,762	600 New	600 $9,000

3.55M

36.9K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $6.59B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.